In the event of any future acquisitions, we may record a portion of the assets we acquire as
goodwill, other indefinite-lived intangible assets and finite-lived intangible assets. We do not amortize goodwill and indefinite-lived intangible assets, but rather review them for impairment on an annual
basis or whenever events or changes in circumstances indicate that their carrying value may not be recoverable. The recoverability of these assets is dependent on our ability to generate sufficient future earnings and cash flows. Changes in
estimates, circumstances or conditions, resulting from both internal and external factors, could have a significant impact on our fair valuation determination, which could then result in a material impairment charge negatively affecting our results
Future sales of our common stock may depress our stock price.
Future sales of substantial amounts of our common stock in the public market, or the perception that these sales could occur, could adversely
affect the price of our common stock and could impair our ability to raise capital through the sale of additional shares.
In the future,
we may also issue our securities if we need to raise capital in connection with a capital raise or acquisitions. The amount of shares of our common stock issued in connection with a capital raise or acquisition could constitute a material portion of
our then-outstanding shares of our common stock.
We are required to evaluate our internal controls over financial reporting under Section 404
of the Sarbanes-Oxley Act and any adverse results from such evaluation, or the failure to develop internal controls necessary for our newly acquired businesses to achieve compliance with Section 404,
could result in a loss of investor confidence in our financial reports and could have an adverse effect on our stock price.
Pursuant to Section 404 of the Sarbanes-Oxley Act, we are required to furnish a report by our management assessing the effectiveness of
our internal control over financial reporting as of the end of our fiscal year. This assessment must include disclosure of any material weaknesses in our internal control over financial reporting identified by management. The report must also
contain a statement that our auditors have issued an attestation report on managements assessment of our internal controls over financial reporting.
If our management identifies one or more material weaknesses in our internal control over financial reporting, we will be unable to assert our
internal control over financial reporting is effective. If we are unable to assert that our internal control over financial reporting is effective presently or in the future (or if our auditors are unable to express an opinion that our internal
controls over financial reporting are effective), we could incur additional costs and expenses to resolve these deficiencies and lose investor confidence in the accuracy and completeness of our financial reports, which could have an adverse effect
on our stock price. As of December 31, 2012, management had determined that our internal control over financial reporting is effective.
Provisions in our amended and restated certificate of incorporation, amended and restated by-laws and Delaware law may prevent or delay an acquisition
of us, which could decrease the trading price of our common stock.
Our amended and restated certificate of incorporation (our
certificate of incorporation) and amended and restated by-laws (our by-laws) contain provisions that are intended to deter coercive takeover practices and inadequate takeover bids and to encourage prospective acquirers to
negotiate with our board of directors rather than to attempt a hostile takeover. These provisions include:
||a board of directors that, until the 2016 annual meeting of stockholders, will be divided into three classes with staggered terms; |
||rules regarding how our stockholders may present proposals or nominate directors for election at stockholder meetings; |